Form EFFECT NLS Pharmaceutics Ltd.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 9, 2025 4:00 P.M. |
| Form: | F-4 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Qivurn Data Centers Inc. Secures Dual U.S. Financial Regulatory Licenses, Laying a Solid Foundation for Global Strategic Financing Compliance
- AGIBOT's 15,000th Robot Rolls Off the Production Line, Marking a New Milestone in Embodied AI Deployment
- Crypto Bull Run 2026: When It Could Start, and the Bullish-by-Default Presale to Watch
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
